Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Activation-Induced Release of the TNF-Family Member BAFF By NK Cells Facilitates Resistance of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis

Julia S Wild, Stefanie Raab, MSc, Benjamin J Schmiedel, PhD, Andreas Maurer, Pascal Schneider, PhD, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2014) 124 (21): 1963.

https://doi.org/10.1182/blood.V124.21.1963.1963

Published: 2014

Journal Articles

TCL1: A Shared Tumor-Associated Antigen for Immunotherapy Against B-Cell Lymphomas

Jinsheng Weng, Ph.D, Seema Rawal, PhD, Hyun Jun Park, Ph.D, Rakesh Sharma, Ph.D, Sattva S. Neelapu, MD

Blood (2011) 118 (21): 105.

https://doi.org/10.1182/blood.V118.21.105.105

Published: 2011

Journal Articles

Safety and Tolerability of the Combination of Interleukin-2 (rIL-2) and Rituximab in Patients with Refractory/Relapsed Follicular Non Hodgkin Lymphoma. Preliminary Data from the Pearl Study.

Nieves Diaz, MD, Eugeny A. Osmanov, MD, Yulia A. Alexeeva, MD, Mikhail Yu Byakhov, MD, Oleg N. Lipatov, MD, Sergey K. Kravchenko, MD, Ilya S. Zuzgin, MD, Felix T. Garzon, MD, Laurence Elias, MD, Philippe Solal-Celigny, MD.

Blood (2005) 106 (11): 4783.

https://doi.org/10.1182/blood.V106.11.4783.4783

Published: 2005

Journal Articles

Analysis and Identification of Serological Tumor Antigens in Patients Treated with the GM-CSF-Gene Transduced-Autologous Tumor Vaccines (GVAX®) for Renal Cell Carcinoma.

Yukoh Nakazaki, Ph.D, Takao Hashiguchi, Fuyumi Takano, Ryo Kurita, Ph.D, Shirley Clift, Dale G. Ando, MD, Shigetaka Asano, MD, DMSc, Kenzaburo Tani, MD, Ph.D

Blood (2004) 104 (11): 5279.

https://doi.org/10.1182/blood.V104.11.5279.5279

Published: 2004

Journal Articles

IL-2 Adenovector-Transduced Autologous Tumor Cells Induce Antitumor Immune Responses in Patients With Neuroblastoma

Laura Bowman, Michael Grossmann, Donna Rill, Michael Brown, Wan-yun Zhong, Barbara Alexander, Thasia Leimig, Elaine Coustan-Smith, Dario Campana, Jesse Jenkins, Diane Woods, Geoffrey Kitchingman, Elio Vanin, Malcolm Brenner

Blood (1998) 92 (6): 1941–1949.

https://doi.org/10.1182/blood.V92.6.1941

Published: 1998

NARROW

Activation-Induced Release of the TNF-Family Member BAFF By NK Cells Facilitates Resistance of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis

TCL1: A Shared Tumor-Associated Antigen for Immunotherapy Against B-Cell Lymphomas

Safety and Tolerability of the Combination of Interleukin-2 (rIL-2) and Rituximab in Patients with Refractory/Relapsed Follicular Non Hodgkin Lymphoma. Preliminary Data from the Pearl Study.

Analysis and Identification of Serological Tumor Antigens in Patients Treated with the GM-CSF-Gene Transduced-Autologous Tumor Vaccines (GVAX®) for Renal Cell Carcinoma.

IL-2 Adenovector-Transduced Autologous Tumor Cells Induce Antitumor Immune Responses in Patients With Neuroblastoma

Email alerts

ASH Publications

American Society of Hematology

Activation-Induced Release of the TNF-Family Member BAFF By NK Cells Facilitates Resistance of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis

TCL1: A Shared Tumor-Associated Antigen for Immunotherapy Against B-Cell Lymphomas

Safety and Tolerability of the Combination of Interleukin-2 (rIL-2) and Rituximab in Patients with Refractory/Relapsed Follicular Non Hodgkin Lymphoma. Preliminary Data from the Pearl Study.

Analysis and Identification of Serological Tumor Antigens in Patients Treated with the GM-CSF-Gene Transduced-Autologous Tumor Vaccines (GVAX®) for Renal Cell Carcinoma.

IL-2 Adenovector-Transduced Autologous Tumor Cells Induce Antitumor Immune Responses in Patients With Neuroblastoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only